






This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
This provider hasn't verified their profile's information. Are you the owner of this center? Claim your listing to better manage your presence on Recovery.com.
This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
You pay directly for treatment out of pocket. This approach can offer enhanced privacy and flexibility, without involving insurance. Exact costs vary based on program and length of stay. Contact the center for specific details.
The Pines & Cady Hill (PACH), founded in 1976 in Columbus, Mississippi, offers residential and outpatient treatment for addiction and co-occurring mental health disorders. The center combines evidence-based, individualized therapy with 12-step support, art therapy, and recreational therapy.
PACH offers long-term addiction treatment focused on trauma and co-occurring disorders. The primary residential program provides 30+ hours of weekly clinical care, including group therapy, psychoeducation, family counseling, and individual therapy. The transitional program helps residents reintegrate by engaging in community activities while receiving continued therapeutic support.
Pines & Cady Hill provides an intensive outpatient program (IOP), caprice recovery living (CRL), and recovery support services to help individuals maintain sobriety while managing daily responsibilities. Programs offer structured living environments, ongoing support, and guidance for long-term recovery.
Recipient of the state opioid response (SOR) grant, PACH supports individuals struggling with opioid use, particularly by utilizing medication assisted treatment (MAT). The most frequent medications used for opioid use disorders are naltrexone and buprenorphine (suboxone). PACH offers individualized MAT plans that require participation in counseling, social support, and clinically recommended services like intensive outpatient, residential treatment, or recovery support for continued eligibility.
This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.

Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT

Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.

Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.

Suboxone®, Subutex®, Sublocade®, Zubsolv®
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. It activates opioid receptors to reduce cravings and withdrawal but has a ceiling effect, meaning it produces less euphoria and respiratory depression than full opioids.
Buprenorphine binds tightly to opioid receptors, blocking other opioids from attaching and reducing the risk of misuse. It's often combined with naloxone (as in Suboxone®) to discourage injection misuse and is available in daily or monthly forms.